Prokidney (PROK) Construction in Progress (2021 - 2026)
Prokidney (PROK) reported Construction in Progress of $19.3 million for Q1 2026, up 418.12% year-over-year from $3.7 million in Q1 2025, and up 31.42% quarter-over-quarter from $14.7 million in Q4 2025.
Prokidney (PROK) Construction in Progress (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Construction in Progress data on file, last reported at $19.3 million in Q1 2026.
- Construction in Progress for Q1 2026 came in at $19.3 million, up 418.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.3 million (up 418.12% YoY), and the FY2025 annual result was $14.7 million, up 500.94% from the prior year.
- Construction in Progress advanced to $19.3 million in Q1 2026 per PROK's latest filing, from $14.7 million in the prior quarter.
- Over five years, Construction in Progress peaked at $19.3 million in Q1 2026 and troughed at $1.0 million in Q3 2022.
- A 5-year average of $6.5 million and a median of $4.5 million in 2025 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2023 and 2024: Construction in Progress jumped 746.16% in 2023, then tumbled 79.64% in 2024.
- A 5-year view of Construction in Progress shows it stood at $1.6 million in 2022, then soared by 441.57% to $8.7 million in 2023, then slumped by 72.01% to $2.4 million in 2024, then soared by 500.94% to $14.7 million in 2025, then jumped by 31.42% to $19.3 million in 2026.
- Business Quant data shows PROK's Construction in Progress at $19.3 million in Q1 2026, $14.7 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 19.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | 14.71 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 9.08 Mn |
| Dec 31, 2023 | 8.74 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Dec 31, 2021 | 351,000.00 |